In vivo assessment of hepatic triglycerides in murine non-alcoholic fatty liver disease using magnetic resonance spectroscopy

被引:39
作者
Corbin, Ian R. [1 ]
Furth, Emma E. [2 ]
Pickup, Stephen [1 ]
Siegelman, Evan S. [1 ]
Delikatny, Edward J. [1 ]
机构
[1] Univ Penn, Sch Med, Dept Radiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2009年 / 1791卷 / 08期
关键词
In vivo MR spectroscopy; Fatty liver; Non-alcoholic steatohepatitis; Non-alcoholic fatty liver disease; Ob/ob mice; Methionine-choline deficiency; NATURAL-HISTORY; ADIPOSE-TISSUE; STEATOHEPATITIS; RAT; ACID; H-1; QUANTIFICATION; STEATOSIS; OBESITY; NMR;
D O I
10.1016/j.bbalip.2009.02.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In vivo H-1 magnetic resonance spectroscopy (MRS) was used to examine the progression of fatty liver in two murine models of progressive hepatic steatosis: leptin-deficient obese (ob/ob) mice and mice maintained on a diet deficient in methionine and choline (MCDD). Ob/ob mice displayed high levels of intracellular hepatic triglycerides as early as 9 weeks after birth, as observed with MRS and histopathology. Single voxel spectra of ob/ob liver displayed strong resonances arising from saturated (1.3 ppm) and unsaturated (2.8 and 5.3 ppm) fatty acyl chains that could be resolved in the absence of water suppression. Hepatic inflammation, induced by lipopolysaccharide administration, led to a significant increase in unsaturated and polyunsaturated fatty acyl chain resonances (P<0.05), indicating a change in the composition of hepatic triglycerides in lipid droplets. Mice maintained on the MCDD displayed histological evidence of hepatic steatosis as early as two weeks, progressing to macrovesicular steatohepatitis at 10 weeks. The histological changes were accompanied by significant increases in saturated and unsaturated fatty acyl chain resonances and a significant decrease in the lipid/(water + lipid) ratio (P<0.05). These results indicate that in vivo H-1 MRS may be a suitable method to monitor the progression of steatohepatitis. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:757 / 763
页数:7
相关论文
共 62 条
[1]   Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The need for biochemical markers [J].
Ahmed, MH .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (03) :372-372
[2]  
ALEXANDERNORTH LS, 1994, J LIPID RES, V35, P1773
[3]  
Andriamampandry MD, 1996, J NUTR, V126, P2020
[4]   NONALCOHOLIC STEATOHEPATITIS - AN EXPANDED CLINICAL ENTITY [J].
BACON, BR ;
FARAHVASH, MJ ;
JANNEY, CG ;
NEUSCHWANDERTETRI, BA .
GASTROENTEROLOGY, 1994, 107 (04) :1103-1109
[5]  
Baker SJ, 1996, ONCOGENE, V12, P1
[6]  
Bollard ME, 2000, MAGNET RESON MED, V44, P201, DOI 10.1002/1522-2594(200008)44:2<201::AID-MRM6>3.0.CO
[7]  
2-5
[8]   Pathology of nonalcoholic steatohepatitis [J].
Brunt, EM .
HEPATOLOGY RESEARCH, 2005, 33 (02) :68-71
[9]   Nonalcoholic steatohepatitis: Definition and pathology [J].
Brunt, EM .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :3-16
[10]   BIOLOGICAL METHYLATION - SELECTED ASPECTS [J].
CANTONI, GL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1975, 44 :435-451